SCHEMBL26063149

SCHEMBL26063149

C=C(C)C(=O)OC(CCCCC)n1cc(-c2ccccc2)c(=O)[nH]c1=S

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 2/20 0.42
MET P08581 1/20 0.37
ALDH1A1 P00352 2/20 0.34
CYP2C19 P33261 2/20 0.34
SIRT2 Q8IXJ6 2/20 0.33
CHRM2 P08172 4/20 0.31
CHRM4 P08173 4/20 0.31
CHRM5 P08912 4/20 0.31
CHRM1 P11229 4/20 0.31
CHRM3 P20309 4/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
PTPN1 P18031 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
KMT2A Q03164 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26063147 0.90 MMP9 (0.36) ASAH1ALDH1A1CYP2C19PTPN1MEN1
SCHEMBL26063163 0.84 CYP2C19 (0.38) ALDH1A1CYP2C19MEN1CYP1A2CYP2C9
SCHEMBL26063139 0.79 ALDH1A1 (0.34) ALDH1A1CYP2C19
SCHEMBL26063142 0.78 CYP2C19 (0.35) ALDH1A1CYP2C19MEN1CYP1A2CYP2C9
SCHEMBL26063145 0.77 MMP2 (0.34) ALDH1A1CYP2C19
SCHEMBL26063155 0.77 ALDH1A1 (0.32) ASAH1ALDH1A1CHRM2CHRM4CHRM5
SCHEMBL26039881 0.75 MET (0.38) ASAH1METALDH1A1SIRT2SIRT1
SCHEMBL26034728 0.73 ASAH1 (0.38) ASAH1METALDH1A1SIRT2CA1
SCHEMBL16694192 0.70 TSHR (0.42) ALDH1A1CYP2C19CA1
SCHEMBL24205206 0.69 POLB (0.41) ASAH1METCYP2C19CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230273456-A1 OPTICALLY ACTIVE DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230273456-A1 OPTICALLY ACTIVE DEVICES PDE6C, PDE6D, PDE6A ASAH1 1077/4885MET 4768/4885ALDH1A1 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.